Health on MSN

Ozempic vs. Wegovy: Which Drug Is Right for You?

Medically reviewed by Mary Choy, PharmD Ozempic is approved to control blood sugar and reduce the risk of heart problems in ...

Metsera Becomes The Prize In Obesity's Biggest Bidding War

Metsera, Inc. is at the center of a bidding war between Novo Nordisk and Pfizer, driving its stock up 20%. Learn more about ...
Nasdaq

Is Novo Nordisk Increasing Dosage to Defend Wegovy's Edge in Obesity?

Novo Nordisk NVO announced that it has submitted a regulatory application to the European Medicines Agency (EMA) seeking approval for a new and higher dose of its popular obesity medication, Wegovy ...

What Is GLP-1 Microdosing and Does It Lead to Weight Loss? Doctors Explain

People are trying mini doses of GLP-1 drugs to lose weight or maintain weight loss, but doctors urge caution, calling the ...
Hosted on MSN

Wegovy vs. Ozempic: Which Is the Better Weight Loss Drug?

Ozempic and Wegovy are both glucagon-like peptide-1 (GLP-1) receptor agonists and contain the active ingredient semaglutide. They share many similarities, and both effectively lower cardiovascular ...

Novo Nordisk to present new data in oral semaglutide 25 mg (Wegovy® in a pill*) and obesity pipeline at ObesityWeek® 2025

Novo Nordisk today announced new data on the investigational oral semaglutide 25 mg will be among 23 abstracts to be ...
GlobalData on MSN

GLP-1RA microdosing trend continues despite “anecdotal evidence”

"GLP-1RA microdosing trend continues despite “anecdotal evidence”" was originally created and published by Pharmaceutical ...